Trans monounsaturated fatty acids in nutrition and their impact on serum lipoprotein levels in man by Mensink, R.P. & Katan, M.B.
Prof. Lipid Res. Vol. 32, No. I, pp. I I  1-122, 1993 0163-7827/93/$24.00 
Printed in Great Britain. All rights reserved © 1993 Pergamon Press Ltd 
TRANS MONOUNSATURATED FATTY  ACIDS IN 
NUTRIT ION AND THEIR  IMPACT ON SERUM 
L IPOPROTEIN  LEVELS IN MAN 
RONALD P. MENSINK* and  MARTIJN B. KATAN~ 
*Department of Human Biology, Limburg University, P.O. Box 616, 6200 MD Maastricht, 
The Netherlands 
tDepartment of Human Nutrition, Agricultural University, Bomenweg 2, 6703 HD Wageningen, 
The Netherlands 
CONTENTS 
I. INTRODUCTION 111 
II. STRUCTURE AND CHEMmTRY 112 
III. HYDROGENATION OF OILS i 12 
A. Industrial hydrogenation 112 
B. Biohydrogenation 113 
IV. ANALYSIS OF TRANS FATTY ACIDS 114 
V. TRANS FATTY ACIDS IN FOODS 114 
A. Plants and vegetables 114 
B. Hydrogenated oils and processed foods 114 
C. Dairy and meat 115 
D. Trans fatty acids in human milk I 15 
VI. CONSUMPTION OF TRANS FATTY ACIDS I 15 
A, Intake in various countries 115 
B. Contribution of specific food items 115 
VII. METABOLISM 116 
VIII. TISSUE LEVELS AND DmT 116 
A. Adipose tissue levels in various countries 117 
B. Other tissues 117 
IX. TRANS FATTY ACIDS AND SERUM LIPIDS AND LIPOPROTEINS 117 
A. Total cholesterol 117 
B. HDL and LDL cholesterol 119 
C, Lipoprotein(a) 120 
D. Triglycerides 120 
E. Plasma apoproteins 120 
F. Positional isomers 120 
X. TmsuE LEVELS OF TRANS FATTY ACIDS AND COgONARY HEART D ~  120 
Xl. SUMMARY AND CONCLUSIONS 121 
ACKNOWLEDGEMENTS 12 I
REFERENCES 121 
I. INTRODUCTION 
Trans fatty acids have been part of the human diet since times immemorial, because they 
occur in small amounts in the milk and body fat of ruminant animals, such as cows and 
sheep. However, large scale production and incorporation of fats high in trans fatty acids 
into foods started almost a hundred years ago, prompted by the requirements of the 
budding margarine industry. Margarine had first been manufactured in 1869 by the French 
scientist Mtge Mourits from beef tallow and skimmed milk, the fluid left after churning 
of milk into butter. Margarine production was initially hampered by a lack of suitable 
butter-like fats and did not really take off until the introduction of hydrogenation. This 
is a widely used process to increase the melting range of oils so as to obtain solid fats and 
to increase the oxidation resistance of the oils. Hydrogenation now permitted industry to 
use a wide variety of marine and vegetable oils for the production of fats with the required 
texture and stability. Trans fatty acids from partially hydrogenated oils have been a 
component of the human diet for most of this century. 
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FIG. 1. Configuration f c~-C18:ln-9 (oleic acid) and trans-C18:ln-9 (elaidic acid). Double bonds 
can be numbered by counting the carbon atoms from either the terminal methyl group, yielding 
the co or n numbering system favoured by nutritionists, or from the carboxyl end, yielding the 
official A numbering system of the International Union of Pure and Applied Chemistry (IUPAC), 
favoured by chemists. Thus, for a molecule with 18 carbon atoms (n-3) or to3 is equivalent toAI5 
and refers to a double bond between the third and the fourth carbon atom from the methyl end 
of the fatty acid molecule. 
II. STRUCTURE AND CHEMISTRY 
All unsaturated fatty acids have at least one carbon-carbon double bond. Because there 
is no rotation around the double bond, it is possible to create two molecules with a different 
configuration (Fig. 1). In the cis configuration the two carbon moieties are on the same 
side of the double bond and in the trans configuration they are on opposite sides. The cis 
configuration produces a bend in the molecule, whereas the trans configuration resembles 
more the straight chain of saturated fatty acids. In this way, two isomers with the same 
number of carbon, hydrogen and oxygen atoms can have a different hree-dimensional 
structure. Such isomers that have their double bonds at the same position in the carbon 
chain, but have different configurations are called geometrical isomers. In addition to this 
spatial isomerism, double bonds may be located at any place along the molecule, so many 
positional isomers may also exist. 
Geometrical and positional isomers have different physical and chemical characteristics. 
Olcic acid (cis-C 18: In-9) and elaidic acid (trans-C 18: ln-9), for example, are geometrical 
isomers: both molecules have eighteen carbon atoms, thirty-four hydrogen atoms, two 
oxygen atoms and a single double bond present at the (n-9) position. The melting point 
of oleic acid is 13 °C, that of elaidic acid 44 °C and of the fully saturated stearic acid 70°C. 
This relatively high melting point makes trans isomers attractive for the production of 
semi-solid cooking fats and margarines. 
III. HYDROGENATION OF OILS 
A. Industrial Hydrogenation 
Hydrogenation of vegetable and in some countries also of marine oils, is applied to 
modify their chemical, physical and sensory characteristics so as make them suitable for 
incorporation i to foods. Depending on the hydrogenation conditions (hydrogen pressure, 
temperature, nature of the catalyst and stirring speed), three types of reaction may occur. 
Hydrogen may add to a cis carbon-carbon double bond, which then becomes aturated 
with hydrogen. For example, complete hydrogenation f linoleic acid (cis, cis-C 18:2n-6) or 
at-finolenic acid (eis, cis, cis-C18:3n-3) produces stearic acid: no double bonds are left. 
Alternatively, the cis configuration may isomerize into a trans configuration, without net 
uptake of hydrogen. Finally, positional isomers can be formed through migration of the 
double bond along the length of the molecule. Strictly speaking, the latter two processes 
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Gjs-monounsaturates 
Cis-C18:1(n-7/L_~11) 
Cis-C18:1(n-8//~10) 
Cis-C18:1(n-9//_39) 
(01eic acid) 
Cis-C18:l(n-10//~8) 
Cis-C18:1(n-11//37) 
I 
1 
Stearic acid 
C18:0 
Trans-monounsaturates 
Trans-C18:1(n-7/A11) 
Trans-C18:1(n-8//_310) 
Trans-C18:1(n-9/L_~9) 
(Elaidic acid) 
Trans-C18:1(n-10/A8) 
Trans-C18:1(n-11//kT) 
I Linoleic acid l 
Cis,cis-C18:2(n-6,9) 1 
Isomers of linoleic acid 
Trans,trans-C18:2 
Cis,trans-C18:2 
Trans,cis-C18:2 
Cis,cis-C18:2 
Fro. 2. Hydrogenation of linoleic acid leads to the formation geometrical nd positional isomers 
of linoleic acid (trans,cis-C 18:2, cis, trans-C 18:2, trans, trans-C 18:2 and cis,cis-C 18:2), of elaidic acid 
and its positional isomers (trans-Cl8:l), of olcic acid and its positional isomers (c/s-C l S: I) and 
to stearic acid (C18:0). 
should be called isomerization and not hydrogenation: although the oil is converted into 
a more solid product, no hydrogen is added to the fatty-acid molecule. 
Thus, partial hydrogenation f vegetable oils, which is applied widely in the edible fats 
industry, produces a complex mixture of fatty acids (Fig. 2). The hardening conditions as 
well as the fatty-acid composition of the feedstock oil determine the exact composition of 
the partially hydrogenated product (Table 1). Trans monounsaturated fatty acids with 
eighteen carbon atoms (trans-C18:l) are typically abundant in hydrogenated vegetable 
oils. However, positional cis isomers of oleic acid are formed as well. 
B. Biohydrogenation 
Hydrogenation of polyunsaturated fatty acids also occurs in the rumen of cows, sheep 
and other uminants. In the absence of oxygen, bacteria use the double bonds of fatty acids 
as acceptors for the hydrogen produced uring metabolism. This leads to saturation of 
dietary unsaturates a  well as to the formation of trans fatty acids. 
TABLE I. Fatty-acid Composition of Soybean Oil 
hydrogenated to Various Degrees 
Degree of hydrogenation 
Nil Low Mid High 
g per 100 g of fatty acids 
Palmitic acid 11 11 11 11 
Stearic acid 4 4 7 11 
C/~-C18:1" 22 29 33 18 
Trans-Cl8:1" 0 12 12 51 
Linoleic acid 54 31 22 0 
Trans-C 18: 2* 0 8 11 9 
~,-Linolenic acid 8 2 2 0 
*C/s-CI8:1 refers to oleic acid and its positional isomers, 
trans-Cl8:1 to elaidic acid and its positional isomers, and 
trans-ClS:2 to all possible geometrical and positional 
isomers of linoleic acid. 
Samples were analyzed by Unilever Research Laboratory, 
Vlaardingen, The Netherlands. 17 
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IV. ANALYSIS OF TRANS FATTY ACIDS 
Infra-red absorption spectrophotometry is the classical technique for the quantification 
of trans fatty acids. It is based on the specific absorption band of the trans double bond 
at about 970 cm-t (10.3 #m). The result is expressed in terms of grams of elaidic acid per 
100 g of fatty acids. Biased values may thus be expected for fatty acids that have a longer 
chain length and/or more than one trans double bond per molecule, such as can be found 
in partially hydrogenated fish oils. The infra-red technique is not sensitive nough for 
reliable quantification of levels of 5% or less. Sensitivity can be improved by the use of 
Fourier-transform infra-red spectroscopy. 
Gas-liquid chromatography appears a convenient technique for the identification and 
quantification of individual trans fatty acids. However, it is complicated by the frequent 
overlap of peaks, especially of the n- 11 and n- 12 (A7 and A6) cis with the n-6 to n-8 (A 12 
to A10) trans isomers of C18:1. Gas-chromatographic figures for trans fatty acids should 
therefore be approached with caution and should preferably be backed up by infra-red 
spectroscopy. 
Trans fatty acids with twenty or twenty-two carbon atoms as present in hydrogenated 
fish oils cannot be reliably resolved by gas chromatography; here infra-red spectroscopy 
is the chosen method. 
V. TRANS FATTY ACIDS IN FOODS 
A. Plants and Vegetables 
Unsaturated fatty acids in vegetable and animal tissues typically have the cis configur- 
ation, while the double bonds are usually located at the n-3, n-6, and/or n-9 positions. 
There are, however, some exceptions. Trans isomers of palmitoleic acid, oleic acid and 
polyunsaturated acids have been identified in leaves and seeds of several plant species, as 
summarized by Sommerfeld. ~ The fat content of leaves, however, is low and although seed 
oils of plants rich in trans fatty acids do exist, ~8 they do not contribute significantly to 
dietary fat intake in man. 
B. Hydrogenated Oils and Processed Foods 
The trans fatty acid content of margarines varies from about 30% in brick-type hard 
margarines made from partially hydrogenated vegetable oil down to less than 1% in 
certain soft diet margarines. The latter are produced by mixing non-hydrogenated 
sunflower oil with a small amount of a fat high in stearic and palmitic acid. Hard, 
high-melting, margarines and shortenings made from partially hydrogenated vegetable oils 
typically contain quantities of trans fatty acids between 20 and 30% of total fatty acids, 
but levels up to 45% can be found. 13.4°'45 Margarines, however, are not the only source of 
trans fatty acids. Partially hydrogenated oils may also be used for the production of breads 
and rolls, parfried French fries, candies, cookies, crackers, mayonnaise, cakes and related 
products and for the preparation of deep-fat fried fast foods. It should be emphasized, 
however, that such products may vary widely in their composition. 13
The double bond distribution of positional trans and cis isomers also varies. Most 
positional trans isomers, however, have their double bond at the n-8 (A10), n-9 (A9) and 
n-10 (AS) position, and most positional cis isomers at the n-9 (A9), n-8 (AI0), n-7 (A11) 
and n-6 (A12) position. 42 
Traditionally, marine oils have been an important raw material for the manufacture of 
margarines. The use of partially hydrogenated fish oil is nowadays largely restricted to the 
United Kingdom, Norway and the Netherlands. During hydrogenation, eicosapentaenoic 
acid (EPA; C20:5n-3) and docosahexaenoic acid (DHA; C22:6n-3), characteristic for fish 
oils, become partially saturated as well as isomerized to trans isomers. The level of trans 
fatty acids of such fats as measured by infra-red absorption is typically 25--45 g 
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per 100 g of fatty acids, 2° most of which is contributed by monounsaturated fatty acids 
with a chain length of 20 or 22 carbon atoms. 44 
C. Dairy and Meat 
Bacteria in the rumen of animals like cows and sheep produce trans fatty acids that can 
be found in their milk and meat. Levels of trans-C18:l in milk fat range from 4 to 10% 
of total fatty acids, ~3'46 although large seasonal variation exists. 38 The isomer composition 
does not vary as much as that of industrially hydrogenated fats. Most trans double bonds 
are located at the (n-7) and to a lesser extent at the (n-9) position. Small amounts of other 
trans isomers, as well as positional cis isomers, are also found in dairy products. 3s'4~ 
D. Trans Fatty Acids in Human Milk 
Trans fatty acids in human milk are derived from the diet. Koletzko et al. 27 studied the 
fatty-acid composition of milk from 15 German mothers during the third or fourth month 
of lactation. The median value for total fat content was 53.5 g/l. Trans fatty acids 
contributed 4.4% of all fatty acids. Seven different trans fatty acids were identified. The 
level of trans-C18:l was 3.1%, but small amounts of less than 0.5% of trans-Cl4:i, 
trans-C16:l, trans-C20:l and trans isomers of linoleic acid were also reported. Chappell 
et al. 6 found levels of 2.8% of trans-Cl8:l in breast milk samples from U.S.A. mothers. 
Several positional isomers of trans-C18:1 were observed, although elaidic acid accounted 
for as much as 2.6%. Also small amounts of trans isomers of linoleic acid were detected, 
but no trans-C14:l and trans-C16:l. Craig-Smith et al. 7 fed eight healthy mothers, 2 
months post-partum, two diets either high or low in hydrogenated fats. Trans-C18:l 
provided on average about 3.5% of total daily energy on the hydrogenated-fat diet, while 
the other diet was practically free of trans-C18:1. An increase in the level of trans-C18:1 
in breast milk was already observed on the second ay on the high-trans diet and a decrease 
on the low-trans diet. This short-term study suggests that the content of trans-Cl8:l in 
the milk is related to its level in the diet of the previous day. It was estimated that each 
increment of 1% of energy from trans-Cl8:l in the diet increased the level in milk by 
0.42% .7 
Infant formula diets may also contain trans fatty acids, although levels are generally 
lower than in human milk. 26'39 
VI. CONSUMPTION OF TRANS FATTY ACIDS 
A. Intake in Various Countries 
The trans- fatty acid content of foods is not given in most nutrient data banks, which 
makes it difficult to obtain a reliable estimate of the current intake. Based on published 
data, the estimated intake of trans-Cl8:1 in Western countries varies between 2 and 12 g 
per day or 5-7*/, of total fatty acids (Mensink and Katan, in preparation). The variation 
in intake between individuals is also very large. 2'52 
B. Contribution of  Specific Food Items 
Margarine and spreads are a major source of trans fatty acids in the diet. Hunter and 
Applewhite 2testimated the contribution of these two food items for the U.S.A. to total 
trans intake at 31%, of industrial fats and oils--used for baked goods, deep-fat frying, 
etc.--at 27*/0 and of meat and dairy products at 17%. For the United Kingdom it was 
estimated that margarines and other fats and oils contributed about 420 to total trans 
intake, milk, butter and other dairy products 14% and meat and meat products also 14°/o. 5
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VII .  METABOLISM 
Conversion into a trans isomer is an obligatory step in the //-oxidation of cis- 
unsaturated fatty acids. Human cells would therefore be expected also to metabolize 
exogenous trans fatty acids. This is indeed what has been found. 
Aspects of the metabolism of positional c/s-C18:1 and trans-C18:1 isomers have been 
reviewed in detail? In man Emken and co-workers have compared the uptake, distribution 
and turnover in human plasma lipids of positional and geometrical isomers of oleic acid. 
For this purpose deuterium-labelled isomers of oleic and elaidic acid were synthesized and 
converted into triacylglycerols. A single dose of these triacylglycerols was then fed as 
liquid-formula diets to two or three healthy volunteers and blood was sampled over the 
next 48 hr. 
In general, the evidence suggested that there is no difference between the absorption of 
oleic acid and its positional or geometrical isomers. After absorption, however, incorpor- 
ation of the isomers into plasma lipids was different. Oleic acid was preferentially 
incorporated into plasma triglycerides and cholesteryl esters as compared with its 
geometrical nd positional isomers. Results for other plasma lipid components were less 
consistent. ~°Oxidation rates and turnover ates may also be slightly different, 9 although 
this does not lead to accumulation of trans fatty acids in human tissues over the years? 4'~ 
If these differences in oxidation rate are real, certain unknown adaptive mechanisms must 
therefore exist to prevent isomeric fatty acids from accumulating. Elongation and 
desaturation occurred, but at very low rates.l° In a study with free-living subjects Melchert 
et al. 31 have compared the fatty acid spectra of serum cholesteryl esters, triglycerides, free 
fatty acids, diglycerides and phosphatidylcholine from the plasma of male and female 
vegetarians and non-vegetarians. Levels of elaidic acid were slightly lower in vegetarians 
than in non-vegetarians. The proportion of elaidic acid, however, differed widely and 
inconsistently between the different lipid fractions. 
The metabolism of the very long chain trans fatty acids from partially hydrogenated fish 
oil in man has been studied much less intensively. However, the fact that these fatty acids 
did not accumulate in the fat tissue of Dutchmen 24 despite a life-long intake of some 5 g 
per day suggests that their catabolism does not present a major problem. 
VII I .  T ISSUE LEVELS AND DIET  
Trans fatty acids in human tissue lipids probably originate solely from dietary sources. 
This intake of trans fatty acids can therefore be estimated by analysis of the fatty-acid 
spectrum of subcutaneous adipose tissue, which is relatively easy to sample. 4 The half-life 
of this fat depot is more than 2 years and its proportion of essential fatty acids--which 
are also completely supplied by the diet--is considered a valid indicator of the average 
intake over the preceding 1-3 years? 
The correspondence b tween levels of trans fatty acids in the diet and the levels present 
in human adipose tissue has not been adequately established. Studies in rats and mice, 
however, suggest hat the relative proportion of trans-Cl8:l in the diet exceeds that in 
adipose tissue. ~2 In humans, London et al? 9 also noted a higher proportion of trans fatty 
acids in the diet than in subcutaneous adipose tissue. In this s tudy  29 with 125 post- 
menopausal women dietary fatty-acid intake was estimated by a semi-quantitative 
questionnaire over the past year. The level of trans-Cl8:1 in adipose tissue was positively 
related to the estimated intake of trans-C18:l in the diet, expressed as g per day or as 
percentage of total fat intake. The Spearman correlation coefficient was about 0.50 
(P < 0.001), similar to values found for the relation between linoleic acid in the diet and 
in adipose tissue. ~ These results uggest that the level of trans.C 18:1 in the diet is reflected 
in adipose tissue. 
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A. Adipose Tissue Levels in Various Countries 
Table 2 shows the trans-fatty acid level in adipose tissue of subjects from the U.S., the 
U.K., Germany, The Netherlands and Israel. Elaidic acid and its positional isomers 
(trans-Cl8:l) are the most abundant and levels range between 2 and 4%. The proportion 
of trans isomers of linoleic acid varies between 0.4 and 1.3% and the contribution of 
trans-C16:l is less than 1%. Two studies 19a9 also reported the presence of trans-Cl4:l at 
levels of 0.05 and 0.12%, respectively. 
The range of values is similar for all countries, with no notable xceptions, which would 
suggest similar levels of dietary trans fatty acids. However, in view of the analytical 
problems involved in the identification of trans fatty acids (see above), these figures should 
be interpreted with caution. Studies from the U.K. 5°'54 reported also small amounts of 
trans-C20:1 and trans-C22:1, which are probably derived from hydrogenated marine oils. 
The distribution of positional trans-C 18:1 as well as cis-C 18:1 isomers in human adipose 
tissue reflects that of partially hydrogenated soy bean oil, 19'37 the major dietary source of 
trans fatty acids in the U.S.A. This also suggests that incorporation i to human fat tissue 
is comparable for the various positional isomers. 
B. Other Tissues 
Levels of trans fatty acids have also been reported for liver, heart, aorta, brain, kidney 
and jejunum tissue lipids. ~,)5'=,25,37 For the same subjects levels were generally lower than 
those in adipose tissue, while trans-C 18:1 was the most prominent trans-fatty acid. Heckers 
et al., ~5 however, noted higher trans-C 16:1 than trans-C18:1 levels in jejunum and aortic 
tissue lipids. 
IX. TRANS FATTY  ACIDS AND SERUM L IP IDS AND L IPOPROTEINS 
Cholesterol is transported in the blood in the form of lipoproteins. The risk of coronary 
heart disease is positively related to the total cholesterol and to the cholesterol level in the 
low-density lipoprotein (LDL) fraction, but negatively to that in the high-density 
lipoprotein (HDL) fraction. ~4 The major apoprotein in LDL is apoprotein B and in HDL 
apoprotein A-I. Another lipoprotein, lipoprotein(a) (Lp(a)), is an LDL-like particle. Its 
protein part is composed of apoprotein B and apoprotein(a). Although Lp(a) does not 
contribute significantly to total cholesterol levels, high levels are associated with increased 
risk for coronary heart disease? a 
As discussed above (Table 1), hydrogenation may increase dietary levels of trans mono- 
and trans polyunsaturated fatty acids, of stearic acid and of positional isomers of oleic acid 
and may decrease the level of ~-linolenic, of linoleic and of oleic acid. Many of the older 
studies on trans fatty acids compared the cholesterolemic potential of partially hydrogen- 
ated oil with that of the original oil. Thus, the level of trans fatty acids was not the sole 
variable between the diets, so that results could not be attributed to specific fatty acids. 
A. Total Cholesterol 
Two of the earlier studies that have examined the effect on serum total cholesterol levels 
of trans-C18:1 yielded conflicting results. Mattson et al) ° fed thirty subjects for three weeks 
a diet high in oleic acid. For the next four weeks 17 subjects continued on the high-oleic 
acid diet, while in the diet of the other men 14% of energy from cis-C18:l was replaced 
by trans-C18:1. Cholesterol intake was 500 mg per day. Changes in serum total cholesterol 
and triglycerides were not different between the two groups. Vergroesen and co-workers 
tested the effects of trans-Cl8:l on serum total cholesterol levels in two separate 
experiments? The first study suggested that 14% of energy from trans-Cl8:l was only 
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hypercholesterolemic in the presence of dietary cholesterol. The authors, however, 
reported that serum total cholesterol levels in a control group fluctuated more than 
normal, which may have biased the changes observed. In their second experiment it was 
shown that, when the intake of cholesterol was 220 mg, 14% of energy from trans-C18:l 
increased serum total cholesterol levels relative to cis-C18:1. Cholesterol-free diets were 
not tested in that study. There is no obvious explanation for the discrepant findings of 
Mattson, Vergroesen and their co-workers: liquid formula diets were employed in both 
studies, subjects had normal total cholesterol levels and dietary periods were long enough 
for serum lipids to stabilize. 
Anderson et al. 3 reported that simultaneous replacement of 3.8% of energy from 
trans-C18:2 by linoleic acid and of 11.0% from trans-C18:l by oleic acid decreased 
serum total cholesterol levels by 0.54 mmol/l (21 mg/dl). Although effects could not be 
attributed solely to trans-C18:l, these results did suggest hat trans-C18:l and/or 
trans-C18:2 raised serum cholesterol. 
B. HDL and LDL Cholesterol 
Mensink and Katan carried out a controlled trial with 25 men and 34 women) 2 
Subjects received in random order a diet high in cis-Cl8:l, one high in trans-C18:l 
and a diet high in the cholesterol-raising saturated fatty acids lauric, myristic and 
palmitic acid. Each diet was fed for three weeks. The level of trans-C18:l on the 
trans-diet was 11% of total energy, which is well above the average level of trans-C18:1 
intake. HDL-cholesterol was 0.17 mmol/1 (7 mg/dl) lower on the trans-diet than on 
the other two diets, while LDL cholesterol was 3.04 mmol/l (118 mg/dl) on the trans- 
diet, 2.67 mmol/l (103 mg/dl) on the cis-C18:l diet and 3.14 retool/! (121 mg/dl) on 
the high-saturated fat diet. Trans-C18:l thus lowered HDL and raised LDL choles- 
terol. This study has been criticized, because of its high level of trans-C18:l. 4~ In a 
second experiment, Zock and Katan compared the effects of 8% of energy from 
trans-Cl8:l on serum lipoproteins with those of linoleic acid and of stearic acid, a 
saturated fat with eighteen carbon atoms) 5Replacement of linoleic acid by trans-Cl8:1 
or stearic acid caused lower HDL cholesterol and higher LDL cholesterol levels. This 
study confirmed the effects on HDL and LDL cholesterol at lower intakes of trans- 
C18:1. 
Nestel and co-workers reported two studies of the effect of trans-C18:l on plasma 
lipoprotein levels. In their first study with 26 mildly hypercholesterolemic ales, two 
different fat blends were compared with a control fat. 35 The fatty-acid composition of the 
two experimental fat blends was nearly identical and contained 7 g per 100 g more 
trans-C18:l, but also 17 g less palmitic acid and 16 g more linoleic acid as compared with 
the control fat. LDL levels were significantly lower on the test blends, while HDL 
cholesterol were slightly, but not significantly, lower. In view of the multiple changes in 
fatty-acid intake, these findings do not necessarily contradict our own results. 32"55 In a 
second study 27 mildly hypercholesterolemic en each received iets enriched with 4.3% 
of oleic acid, elaidic acid or palmitic acid for 3 weeks. As compared with the oleic acid 
diet both the plasma total and LDL cholesterol increased by 0.36 mmol/1 (14 mg/dl) on 
the elaidic acid diet and by 0.28 and 0.26 mmol/l (11 and 10 mg/dl) mg/dl, respectively, 
on the palmitic acid diet. HDL cholesterol levels were 0.10 mmol/i (4 mg/dl) higher on 
the palmitic diet than on the other two test diets. The authors concluded that elaidic and 
palmitic acid are equally hypercholesterolemic. Nestel et al. did not report a HDL-choles- 
terol lowering effect of trans-C18:l. 36 Recently, Judd and co-workers at the Beltsville 
Agricultural Research Center of the U.S. Department of Agriculture completed a large, 
well-controlled trial on the effect of partially hydrogenated soybean oil on lipoprotein in 
volunteers. According to preliminary results (Food Chemical News, August 31, 1992, p. 3) 
this study supported our earlier findings 32"55 that trans-C18:l lower HDL cholesterol and 
raise LDL cholesterol. 
120 R.P. MENS|NK and M. B. KATAN 
C. Lipoprotein(a ) 
Plasma levels of Lp(a) were hitherto thought o be impervious to effects of diet. Two 
recent independent papers, however, eported that trans-C 18:1 increases serum Lp(a) levels 
relative to c/s-C18:1, to linoleic acid, or to saturated fatty acids, u'36 This effect was dose 
dependent. ~ 
D. Triglycerides 
Anderson et al. 3 reported a triglyceride-elevating effect of trans fatty acids, but Mattson 
et al. 3° found similar plasma triglycerides levels on the trans-C18: l-diet and the diet high 
in oleic acid. Mensink and Katan, however, found that trans-Cl8:l raised serum 
triglycerides relative to oleic acid, but not relative to the cholesterol-raising saturated fatty 
acids. Zock and Katan also noted slightly higher serum triglyceride levels on the 
trans-C1 8:1-diet han on the linoleate-diet, although the difference did not reach statistical 
significance. Levels on the stearate-diet were comparable to those on the trans-C 18" 1 diet. 
Finally, Nestel et al. 36 found that increasing the intake of trans-C18:l by 4.3% of total 
energy at the expense of oleic acid increased plasma triglycerides by 0.08 mmol/l (7 mg/dl). 
Levels on the diet high in palmitic acid, however, were the lowest, but none of these 
differences did reach statistical significance. The results of these studies together suggest 
that trans-Cl8:l isomers have the potential to raise serum triglycerides. 
E. Plasma Apoproteins 
In the study of Mensink and Katan 32 apoprotein B levels were somewhat higher on the 
trans-C18:1 diet than on the saturated-fat diet, but considerably ower on the oleic acid 
diet. The changes observed id not entirely parallel those of LDL cholesterol, which was 
highest on the diet high in the cholesterol-raising saturated fatty acids. Zock and Katan 5~ 
showed that the trans diet also increased apoprotein B levels relative to the linoleate diet 
and were intermediate onthe stearic diet. These findings together suggest that trans-Cl 8:1 
increases the ratio of apoprotein B to cholesterol in LDL relative to the most common 
saturated fatty acids in the diet. This could be interpreted as showing a shift toward 
smaller, denser LDL on diets high in trans-C18" 1. However, this is a conjecture that needs 
to be investigated directly. 
In both studies 32'55 the diet high in trans-Cl8:l caused the lowest apolipoprotein A-I 
levels and changes parallelled those of HDL cholesterol. 
F. Positional Isomers 
Theoretically, the different positional isomers of elaidic acid may have different effects 
on serum lipids and lipoproteins. In addition, the effects ascribed above to trans-C 1 8:1 may 
also be, at least partly, due to the positional cis isomers invariably present in hydrogenated 
oils. a3'42 These differences--if any--are probably not large: the spectrum of positional cis- 
and trans-C18:l isomers in the fats used for our two studies was quite different, while the 
effect on serum HDL and LDL cholesterol levels, expressed per percent of energy, were 
nearly similar. 55 
X. TISSUE LEVELS OF TRANS FATTY ACIDS AND CORONARY HEART DISEASE 
A possible relationship between the intake of trans fatty acid and risk for coronary heart 
disease has been examined by analyzing post-mortem tissue samples. Heckers et al.'5 could 
not demonstrate a relationship between the degree of atherosclerosis and the level of trans 
fatty acids in lipids from myocardium, jejunum or aorta tissue. In two studies Thomas et al. 
did find higher levels of trans-C16:l from hydrogenated marine oils, hut not of trans- 
C18:147.5°'5' or total trans fatty acids, 5t in adipose tissue of males who died of coronary 
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heart disease as compared with controls. Cases and controls, however, were not matched 
and effects o f  possible confounding variables were not accounted for. At present, there 
appears to be no strong evidence that high tissue levels of  trans fatty acids per  se are 
associated with increased risk for coronary heart disease. 
x I .  SUMMARY AND CONCLUSIONS 
Trans -C l  8:1 in the diet originate predominantly from partially hydrogenated oils, with 
beef, mutton and dairy products being an additional source. These fatty acids are absorbed 
and incorporated into lipids. Their estimated consumption is about 5-7% of  total fatty 
acids, although reliable data are lacking. In addition, large variations between individuals 
exist. There is no evidence that trans fatty acids accumulate in human tissues. Elaidic acid 
and its positional isomers do, however, raise LDL  cholesterol and apoprotein B and Lp(a) 
and probably depress HDL cholesterol and apoprotein A-I,  compared with the cis isomer, 
oleic acid. In view of  these adverse effects, patients at high risk for atherosclerosis, in
addition to reducing their intake of  saturated fatty acids and of  cholesterol might also do 
well to avoid excessive intakes of  trans fatty acids. Still, trans fatty acids form only a minor 
component of  the diets of  most patients and therefore ven marked relative reductions in 
intake will probably have less of  an impact on LDL  cholesterol than a sizeable reduction 
in saturated fatty acids and cholesterol will produce. 
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